1. Home
  2. IRMD vs ABCL Comparison

IRMD vs ABCL Comparison

Compare IRMD & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$97.44

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.38

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRMD
ABCL
Founded
1992
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
IRMD
ABCL
Price
$97.44
$3.38
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$72.00
$7.75
AVG Volume (30 Days)
78.2K
3.1M
Earning Date
02-12-2026
11-06-2025
Dividend Yield
0.70%
N/A
EPS Growth
13.00
N/A
EPS
1.65
N/A
Revenue
$80,511,268.00
$35,325,000.00
Revenue This Year
$15.17
$25.45
Revenue Next Year
$10.15
$10.07
P/E Ratio
$58.96
N/A
Revenue Growth
12.91
7.17
52 Week Low
$47.48
$1.89
52 Week High
$98.53
$6.52

Technical Indicators

Market Signals
Indicator
IRMD
ABCL
Relative Strength Index (RSI) 65.76 37.88
Support Level $90.92 $3.32
Resistance Level $98.53 $3.82
Average True Range (ATR) 2.27 0.17
MACD -0.41 0.02
Stochastic Oscillator 85.81 12.04

Price Performance

Historical Comparison
IRMD
ABCL

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: